Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-08-008115
Filing Date
2008-07-11
Accepted
2008-07-11 11:26:19
Documents
5
Period of Report
2008-08-22
Effectiveness Date
2008-07-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2186794zdef14a.htm DEF 14A 483475
2 G109798.JPG g109798.jpg GRAPHIC 3138
3 G461364.JPG g461364.jpg GRAPHIC 3878
4 G183572BAI001.JPG g183572bai001.jpg GRAPHIC 4112
5 G183572BCI001.JPG g183572bci001.jpg GRAPHIC 4112
  Complete submission text file 0001047469-08-008115.txt   506548
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 1850 LAKESIDE DRIVE WAUKEGAN IL 60085 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: DEF 14A | Act: 34 | File No.: 001-12493 | Film No.: 08948392
SIC: 2836 Biological Products, (No Diagnostic Substances)